Tocilizumab Approved by the FDA for SSc-induced ILD: Does It Improve the Rate of Lung Function & What Are the Dosing Recommendations? What Is the Association Between Gout and Weight?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Tocilizumab Approved by the FDA for SSc-induced ILD: Does It Improve the Rate of Lung Function & What Are the Dosing Recommendations? What Is the Association Between Gout and Weight?

By RheumNow FEATURING John J. Cush

586 views

March 15, 2021

Comments 0

Expert Perspectives on CSU

Feat. T. Murphy

Barriers in Diagnosing Fibrosing Interstitial Lung Diseases (ILDs)

Feat. M. Zlupko

ATS 2022: Approach to Lung Nodules in 2022

Shaheen Islam

12.7K views

Post COVID-19 Lung Complications

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

M. Padilla

8.8K views

Approaching Sarcoidosis Therapy From a 21st Century Perspective

CHEST 2022 Coverage

D. Culver

7.0K views

A Radiologist's Approach to Subsolid Pulmonary Nodules

CHEST 2022 Coverage

A. Guttentag

5.3K views

Advances and Updates in Sarcoidosis: Diagnosis and Treatment of Pulm…

UCLA Health

J. Belperio

4.4K views

New

Analysis of Gout Remission Definitions in a Randomized Controlled Tr…

The Journal of Rheumatology

E. Silverman, D. Tabi-Amponsah, N. Dalbeth

37 views

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

4.3K views

Bronchoscopic Imaging for Interstitial Lung Disease

CHEST 2022 Coverage

G. Zhi Cheng

5.0K views

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

CHEST 2022 Coverage

T. Kulkarni

4.8K views

Sarcoidosis: Diagnosis and Management

University of Colorado Department of Medicine

N. Held

3.8K views

Interstitial Lung Disease in RA: RA-ILD Subtypes, Mortality Risk, RA…

RheumNow

J. Sparks, J. Cush

182 views

Rituximab versus Cyclophosphamide for the Treatment of Connective Ti…

Toby Maher

3.2K views

Management of Pulmonary Fibrosis in Clinical Practice

National Jewish Health

J. Solomon

2.6K views

EADV 2024 Insights: Eosinophilic Fasciitis

EADV 2024 Insights

F. Rongioletti

197 views

New

Classification, Diagnosis and Management of Pulmonary Hypertension: …

Icahn School of Medicine at Mount Sinai

R. Benza

49 views

Defining the Molecular Natural History of Early and Progressive Pulm…

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

N. Banovich

49 views

Challenges in ILD: Prediction With or Without Big Data

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

T. Fingerlin

102 views

Current and Evolving Paradigm of Anti-Inflammatory Therapy in Pulmon…

Temple Lung Center

R. Gupta

651 views

Interstitial Lung Disease: Multidisciplinary Discussion

UCLA Health

S. Sam Weigt, E. R. Volkmann, F. Abtin, M. Fishbein

3.3K views

Medical Marijuana in Rheumatology: Fact or Fiction?

Keck School of Medicine of USC

A. Wells

459 views

AUTOPLAY

Login

Login

Join VuMedi

Tocilizumab Approved by the FDA for SSc-induced ILD: Does It Improve the Rate of Lung Function & What Are the Dosing Recommendations? What Is the Association Between Gout and Weight?

Expert Perspectives on CSU

Barriers in Diagnosing Fibrosing Interstitial Lung Diseases (ILDs)

Related Videos

ATS 2022: Approach to Lung Nodules in 2022

Post COVID-19 Lung Complications

Approaching Sarcoidosis Therapy From a 21st Century Perspective

A Radiologist's Approach to Subsolid Pulmonary Nodules

Advances and Updates in Sarcoidosis: Diagnosis and Treatment of Pulm…

Analysis of Gout Remission Definitions in a Randomized Controlled Tr…

Interstitial Lung Disease in Rheumatic Diseases

Bronchoscopic Imaging for Interstitial Lung Disease

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

Sarcoidosis: Diagnosis and Management

Interstitial Lung Disease in RA: RA-ILD Subtypes, Mortality Risk, RA…

Rituximab versus Cyclophosphamide for the Treatment of Connective Ti…

Management of Pulmonary Fibrosis in Clinical Practice

EADV 2024 Insights: Eosinophilic Fasciitis

Classification, Diagnosis and Management of Pulmonary Hypertension: …

Defining the Molecular Natural History of Early and Progressive Pulm…

Challenges in ILD: Prediction With or Without Big Data

Current and Evolving Paradigm of Anti-Inflammatory Therapy in Pulmon…

Interstitial Lung Disease: Multidisciplinary Discussion

Medical Marijuana in Rheumatology: Fact or Fiction?